Metoprolol Tartrate Injection, Solution
Product Images NDC 51662-1478

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Metoprolol Tartrate (NDC 51662-1478). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adverse (Adverse Reactions 1)

A data table comparing incidence rates of adverse events for Metoprolol Tartrate versus Placebo, including hypotension, bradycardia, second- or third-degree heart block, first-degree heart block, and heart failure, with percentages noted for each condition in both groups.*

FDA Label Image

Logo (How Supplied Logo)

FDA Label Image

How Supplied (How Supplied)

A data table listing packaging information for Metoprolol Tartrate injection. It shows a unit of sale with NDC 0409-1778-05 as a carton of 10 vials, concentration of 5 mg/5 mL (1 mg/mL), and individual vials identified by NDC 0409-1778-15 as single dose glass fliptop vials.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Vial Labeling (Serialized Labeling)

Metoprolol Tartrate Injection, USP 1 mg/mL in a 5 mL single-dose vial for intravenous use. The vial label includes storage instructions, a barcode, and the labeler information: HF Acquisition Co LLC, DBA HealthFirst. The vial is sealed with a gray flip-top cap.*

FDA Label Image

Structure (Structure)

Chemical structure of metoprolol tartrate, the active ingredient in METOPROLOL TARTRATE injection, solution 1 mg/mL. The structure shows the molecular components including the aromatic ring and tartrate salt moieties.*

FDA Label Image

Vial Label Option 1 (Vial Label Option 1)

Label for Metoprolol Tartrate Injection, USP 1 mg/mL (5 mg/5 mL) single-dose vial. The label states it is for intravenous use and to protect from light. Distributor is Hospira, Inc., Lake Forest, IL, USA, with storage instructions at 20 to 25°C (68 to 77°F). The label includes the NDC 0409-1778-15 and displays the Hospira logo.*

FDA Label Image

Vial Label Option 2 (Vial Label Option 2)

Label for Metoprolol Tartrate Injection, USP, intravenous solution with a strength of 5 mg per 5 mL (1 mg/mL) in a 5 mL single-dose vial. Labeled for prescription use only with storage instructions and manufacturer information for Hospira, Inc., Lake Forest, IL, USA.*

FDA Label Image

Vial Label Option 3 (Vial Label Option 3)

Label for Metoprolol Tartrate Injection, USP intravenous solution, strength 5 mg/5 mL (1 mg/mL) single-dose vial. The label instructs storage at 25°C, protection from light, and notes Rx only. Distributed by Hospira, Inc., Lake Forest, IL, with a visible barcode and lot information.*

FDA Label Image

Warning (Warnings)

A text panel titled 'Ischemic Heart Disease' describing precautions related to discontinuing metoprolol tartrate therapy in patients with coronary artery disease. It advises against abrupt discontinuation and outlines the need for gradual dose reduction and monitoring to prevent exacerbation of angina, myocardial infarction, and arrhythmias.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.